跳至主要内容
临床试验/NL-OMON35482
NL-OMON35482撤回3 期

Prevention of delirium in acute stroke - PODIAS

Kennemer Gasthuis0 个研究点目标入组 300 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
撤回
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Patients with (suspected) stroke
  • - no delirium on admission (DRS<12; CAM < 2+1)
  • - expected duration of hospitalisation >48 hours
  • - Score on deliersticker * 5
  • - Time between admission and estimation of risk score and DRS/CAM < 24 hours

排除标准

  • - Score deliersticker < 5
  • - delirium on admission (DRS> 12; CAM * 2+1; CAM-ICU * 2 + 1)
  • - not able to perform delirum screening (DRS, CAM, CAM-ICU) on admission
  • - expected duriong of hospitalisation < 48 uur
  • - contraindication for use of haloperidol: history of allergy for haloperidol, severe liverinsufficiency, Parkinson's disease, Lewy body dementia, parkinsonism, epilepsy, use of levodopa/dopamine agonist, use of antipsychotics (e.g., haloperidol) or cholinesterase inhibitors
  • - Pronged Qt interval: Qt interval on EKG on admission * 500ms .
  • - Time between admission and estimation of risk score and DRS/CAM < 24 hours
  • - Participation in same study in the last three months
  • - severe impairment of consciousness (coma)
  • - not possible to obtain informed consent
  • - Patients, family of physician refuse to participate

研究者

发起方
Kennemer Gasthuis

相似试验